semaglutide class action The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can treat alcohol use disorder in veterans. More Below 🔗⬇️ Ozempic Lawsuit: August 2026 Blindness

Grapevine trunk diseases: complex and still poorly understood

GLP-1 may help promote weight loss by suppressing appetite and slowing digestion to promote a longer feeling of fullness

The FDA declared both the semaglutide and tirzepatide shortages resolved in late 2024 and early 2025, and compounding pharmacies were required to stop producing essentially identical copies by mid-2025

Dining Out Is About More Than Just the Food GLP-1 users are no strangers to eating out

It has proven benefits for the skin, and it has shown promise in scientific studies for anti-aging, wound healing, and anti-inflammatory and antioxidant power